Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-017279
Filing Date
2024-02-20
Accepted
2024-02-20 17:33:58
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 meip_s-3_feb_2024.htm S-3 436332
2 EX-5.1 meip-ex5_1.htm EX-5.1 46189
3 EX-23.2 meip-ex23_2.htm EX-23.2 3865
4 EX-FILING FEES meip-exfiling_fees.htm EX-FILING FEES 86609
5 GRAPHIC img94900194_0.jpg GRAPHIC 8009
6 GRAPHIC img94900194_1.jpg GRAPHIC 8009
7 GRAPHIC img94900194_2.jpg GRAPHIC 3672
8 GRAPHIC img94900194_3.jpg GRAPHIC 8009
9 GRAPHIC img185650553_0.jpg GRAPHIC 8155
10 GRAPHIC img185650553_1.jpg GRAPHIC 1140
11 GRAPHIC img185650553_2.jpg GRAPHIC 1148
  Complete submission text file 0000950170-24-017279.txt   627687
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-277201 | Film No.: 24655167
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)